JP2008150375A5 - - Google Patents

Download PDF

Info

Publication number
JP2008150375A5
JP2008150375A5 JP2007322260A JP2007322260A JP2008150375A5 JP 2008150375 A5 JP2008150375 A5 JP 2008150375A5 JP 2007322260 A JP2007322260 A JP 2007322260A JP 2007322260 A JP2007322260 A JP 2007322260A JP 2008150375 A5 JP2008150375 A5 JP 2008150375A5
Authority
JP
Japan
Prior art keywords
iron
release
hemochromatosis
intestine
organs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007322260A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008150375A (ja
JP5456969B2 (ja
Filing date
Publication date
Priority claimed from EP06126122A external-priority patent/EP1932807A1/en
Application filed filed Critical
Publication of JP2008150375A publication Critical patent/JP2008150375A/ja
Publication of JP2008150375A5 publication Critical patent/JP2008150375A5/ja
Application granted granted Critical
Publication of JP5456969B2 publication Critical patent/JP5456969B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2007322260A 2006-12-14 2007-12-13 製造方法 Active JP5456969B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP06126101.2 2006-12-14
EP06126122.8 2006-12-14
EP06126122A EP1932807A1 (en) 2006-12-14 2006-12-14 Inorganic compounds
EP06126101 2006-12-14

Publications (3)

Publication Number Publication Date
JP2008150375A JP2008150375A (ja) 2008-07-03
JP2008150375A5 true JP2008150375A5 (enExample) 2011-02-03
JP5456969B2 JP5456969B2 (ja) 2014-04-02

Family

ID=38983614

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007322260A Active JP5456969B2 (ja) 2006-12-14 2007-12-13 製造方法

Country Status (23)

Country Link
US (2) US8252310B2 (enExample)
JP (1) JP5456969B2 (enExample)
KR (1) KR20090094820A (enExample)
AR (1) AR064301A1 (enExample)
AU (1) AU2007331482B2 (enExample)
BR (1) BRPI0720272A2 (enExample)
CA (1) CA2671828C (enExample)
CL (1) CL2007003606A1 (enExample)
EC (1) ECSP099410A (enExample)
ES (1) ES2526171T3 (enExample)
IL (1) IL198548A0 (enExample)
MA (1) MA30993B1 (enExample)
MX (1) MX2009006307A (enExample)
MY (1) MY151047A (enExample)
NO (1) NO342285B1 (enExample)
NZ (1) NZ576672A (enExample)
PE (1) PE20081381A1 (enExample)
PT (1) PT2319804E (enExample)
RU (1) RU2447933C2 (enExample)
SI (1) SI2319804T1 (enExample)
TN (1) TN2009000214A1 (enExample)
TW (1) TWI465239B (enExample)
WO (1) WO2008071747A1 (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9720061D0 (en) 1997-09-19 1997-11-19 Crosfield Joseph & Sons Metal compounds as phosphate binders
MY157620A (en) 2006-01-31 2016-06-30 Cytochroma Dev Inc A granular material of a solid water-soluble mixed metal compound capable of binding phosphate
GB0714670D0 (en) 2007-07-27 2007-09-05 Ineos Healthcare Ltd Use
GB0720220D0 (en) 2007-10-16 2007-11-28 Ineos Healthcare Ltd Compound
TWI592159B (zh) 2007-11-16 2017-07-21 威佛（國際）股份有限公司 藥學組成物
JP2009292119A (ja) 2008-06-09 2009-12-17 Alps Electric Co Ltd サーマルヘッド
WO2009150232A2 (en) * 2008-06-13 2009-12-17 Novartis Ag Manufacture process for the preparation of an iron containing phosphate adsorbent
GB0814326D0 (en) * 2008-08-05 2008-09-10 Medical Res Council Phosphate binding materials and their uses
CN102573807A (zh) 2009-07-21 2012-07-11 凯克斯生物制药公司 柠檬酸铁剂型
GB0913525D0 (en) 2009-08-03 2009-09-16 Ineos Healthcare Ltd Method
GB201001779D0 (en) 2010-02-04 2010-03-24 Ineos Healthcare Ltd Composition
DE102011112898A1 (de) 2011-09-08 2013-03-14 Charité - Universitätsmedizin Berlin Nanopartikuläres Phosphatadsorbens basierend auf Maghämit oder Maghämit/Magnetit, dessen Herstellung und Verwendungen
CA2849926C (en) * 2011-10-13 2020-07-21 Vidasym, Inc. Iron-fiber composition, preparation and uses thereof
RU2496722C1 (ru) * 2012-04-10 2013-10-27 Леонид Асхатович Мазитов Способ очистки сточной воды от фосфатов
CN109497565B (zh) 2013-03-08 2021-10-26 上海礼邦医药科技有限公司 金属离子-功能性纤维组分络合物组合物、其制备及用途
HK1216513A1 (zh) * 2013-03-15 2016-11-18 阿普雷奇亚制药有限责任公司 包含左乙拉西坦的快速分散劑型
US9339489B2 (en) * 2013-03-15 2016-05-17 Aprecia Pharmaceuticals Company Rapid disperse dosage form containing levetiracetam
WO2015078900A1 (en) 2013-11-27 2015-06-04 Vifor (International) Ag Pharmaceutical composition, comprising phosphate binder particles
US10172882B2 (en) 2014-06-22 2019-01-08 Dexcel Pharma Technologies Ltd. Pharmaceutical compositions comprising ferric citrate and methods for the production thereof
US9901918B2 (en) * 2015-03-04 2018-02-27 Graver Technologies Llc Hybrid ion exchange material and method for making the same
CN105193844A (zh) * 2015-05-27 2015-12-30 合肥川迪医药技术有限公司 用于制备含δ-羟基氧化铁(多核)及其药物组合物的方法及在高磷血症领域中的应用
WO2017172633A1 (en) * 2016-03-28 2017-10-05 New Sky Energy Intellectual Property Holding Company, Llc Methods of producing ferrihydrite nanoparticle slurries, and systems and products employing the same
WO2020025552A1 (en) 2018-07-30 2020-02-06 Interquim, S.A. Process for preparing an adsorbent for phosphate in aqueous medium
CN115175670B (zh) * 2020-01-16 2024-08-30 威佛费森尤斯医疗肾脏药物有限公司 羟基氧化铁(iii)、蔗糖和一种或更多种淀粉的混合物的颗粒，优选羟基氧化蔗糖铁的颗粒
CN115317494B (zh) * 2022-07-22 2024-02-13 康瑞鑫(天津)药物研究院有限公司 高磷酸盐结合力的蔗糖氢氧化氧铁及其制备方法
WO2025096992A1 (en) * 2023-11-01 2025-05-08 Navinta, Llc Process for isolation of solid ferric derisomaltose

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2885393A (en) * 1956-02-24 1959-05-05 R K Laros Company Dextran-iron complex and process for making same
US3697502A (en) * 1969-11-03 1972-10-10 Christensen Henry M Method of making iron dextran-preparations
US3951821A (en) * 1972-07-14 1976-04-20 The Dow Chemical Company Disintegrating agent for tablets
US4180567A (en) * 1977-09-02 1979-12-25 Pharmachem Corporation Iron preparations and methods of making and administering the same
DE3026868C2 (de) * 1980-07-16 1986-03-13 Laboratorien Hausmann AG, St. Gallen Verfahren zur Herstellung von Eisen(III)hydroxid-Dextran-Komplexen und sie enthaltende pharmazeutische sterile wäßrige Lösung
US4569836A (en) * 1981-08-27 1986-02-11 Gordon Robert T Cancer treatment by intracellular hyperthermia
EP0330801A1 (en) * 1983-02-08 1989-09-06 Schering Aktiengesellschaft Ferromagnetic, diamagnetic or paramagnetic particles useful in the diagnosis and treatment of disease
DE3422249A1 (de) * 1984-06-15 1985-12-19 Pfeifer & Langen, 5000 Köln Wasserloesliches eisendextran und verfahren zu seiner herstellung
DE3572440D1 (en) * 1984-06-19 1989-09-28 Basf Ag Gastro-resistant cylindrical pancreatine-microtablets
US4827945A (en) * 1986-07-03 1989-05-09 Advanced Magnetics, Incorporated Biologically degradable superparamagnetic materials for use in clinical applications
US5055288A (en) * 1987-06-26 1991-10-08 Advanced Magnetics, Inc. Vascular magnetic imaging method and agent comprising biodegradeable superparamagnetic metal oxides
US4970079A (en) * 1989-06-05 1990-11-13 Purdue Research Foundation Method and composition of oxy-iron compounds for treatment of hyperphosphatemia
IL98744A0 (en) * 1990-07-06 1992-07-15 Gen Hospital Corp Method of studying biological tissue using monocrystalline particles
SU1807606A1 (ru) * 1991-03-29 1995-08-09 Пермский политехнический институт Способ получения анионообменника на основе гидроксида титана
US5234697A (en) * 1992-06-22 1993-08-10 Digestive Care Inc. Compositions of gastric acid-resistant microspheres containing salts of bile acids
DE69320120T2 (de) 1992-09-04 1999-04-08 Mitsubishi Chemical Corp., Tokio/Tokyo Verfahren zur Herstellung und Verwendung eines Anionen- austauscherharzes
DE4239442C2 (de) * 1992-11-24 2001-09-13 Sebo Gmbh Verwendung eines mit polynuklearen Metalloxidhydroxiden modifizierten Adsorptionsmaterials zur selektiven Elimination von anorganischem Phosphat aus proteinhaltigen Flüssigkeiten
DE19547356A1 (de) * 1995-12-19 1997-06-26 Vifor Int Ag Adsorbens für Phosphat aus wäßrigem Medium, dessen Herstellung und Verwendung
US5906978A (en) * 1996-08-14 1999-05-25 Hemocleanse, Inc. Method for iron delivery to a patient by transfer from dialysate
GB9720061D0 (en) 1997-09-19 1997-11-19 Crosfield Joseph & Sons Metal compounds as phosphate binders
DE10128511A1 (de) * 2001-06-13 2002-12-19 Sebo Gmbh Verwendung eines Phosphatadsorbers gegen Gefäßerkrankungen
WO2003053565A1 (en) * 2001-12-21 2003-07-03 Muromachi Chemical Co., Ltd. Adsorbent for phosphoric acid
DE102004031181A1 (de) 2004-06-28 2006-01-19 Vifor (International) Ag Phosphatadsorbens

Similar Documents

Publication Publication Date Title
JP2008150375A5 (enExample)
JP2011522896A5 (enExample)
IL259851A (en) Compounds and methods of inhibiting antidepressant nhe mediator in the treatment of disorders associated with fluid retention or overload of salts and gastrointestinal disorders
JP2007521835A5 (enExample)
EP2583978A3 (en) Prevention and treatment of synucleinopathic and amyloidogenic disease
Sharkey et al. Use of antibodies and immunoconjugates for the therapy of more accessible cancers
LU92484I2 (fr) Paclitaxel formulé comme albumine liée à des nanoparticules
NZ589445A (en) Rasagiline for parkinson's disease modification
JP2009530288A5 (enExample)
EP1834637A4 (en) COMPOSITION FOR THE PREVENTION / TREATMENT OF DISEASES THROUGH FREE RADICALS
IL180565A0 (en) An improved stopcock for administering medicaments into the patient's body
IL229255A (en) Use of sodium arsenite sodium to make a pharmacological preparation for tissue or organ rejection and treatment kit
WO2009002867A3 (en) Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
MY153408A (en) Novel methods
MX2009011357A (es) Derivados de tetrahidropirido[4,3-d] pirimidinona y metodos de uso de los mismos.
IL213214A0 (en) Nitrate derivatives of cilostazol for the treatment of vascular and metabolic diseases
WO2008149802A1 (ja) アンドログラホリドを有効成分とする抗疲労剤及び経口組成物
IL178815A0 (en) The treatment of respiratory disease
PL2234631T3 (pl) Związki i metody stosowane w terapii choroby naczyniowej
WO2007023154A3 (de) EISEN(III)-KOMPLEXVERBINDtMGEN ZUR BEHANDLUNG VON EISENMANGEL-ZUSTÄNDEN BEI PATIENTEN MIT CHRONISCH-ENTZÜNDLICHER DARMERKRANKUNG
UA97440C2 (en) Use of s-adenosylmethionine (sam) and superoxide dismutase (sod) for the preparation of medicaments for the treatment of alzheimer's disease
TW200626133A (en) Oral medication for twice-daily administration
RU2007104920A (ru) Способ уменьшения токсического повреждения печени
RU2008137014A (ru) Способ коррекции психовегетативных нарушений у пациентов с желчно-каменной болезнью после холецистэктомии
Robb-Nicholson By the way, doctor. I keep hearing that aspirin can help prevent colon cancer, but I have no idea how much I should take. Can you help? I've had adenomatous polyps in the past